Impact of Simeprevir Versus Telaprevir Triple Therapy for Chronic Hcv Infection on Patient-Reported Outcomes in Prior Non-Responders to Peginterferon/Ribavirin Results from the Phase Iii Attain Study

Authors :: Chris Corbett
Jane Scott
W. Jessner
L. Gilles
George J. Wan
U. Sbarigia
Source :: Value in Health. 17:A682
Publication Year :: 2014
Publisher :: Elsevier BV, 2014.

Subjects :: Simeprevir
Non responders
medicine.medical_specialty
business.industry
Health Policy
Internal medicine
Public Health, Environmental and Occupational Health
Medicine
business
PEGINTERFERON/RIBAVIRIN
Gastroenterology
Telaprevir
medicine.drug

Tools